JP2009517406A5 - - Google Patents

Download PDF

Info

Publication number
JP2009517406A5
JP2009517406A5 JP2008542538A JP2008542538A JP2009517406A5 JP 2009517406 A5 JP2009517406 A5 JP 2009517406A5 JP 2008542538 A JP2008542538 A JP 2008542538A JP 2008542538 A JP2008542538 A JP 2008542538A JP 2009517406 A5 JP2009517406 A5 JP 2009517406A5
Authority
JP
Japan
Prior art keywords
assay
cells
clones
serum
samples
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008542538A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009517406A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/061285 external-priority patent/WO2007114861A2/en
Publication of JP2009517406A publication Critical patent/JP2009517406A/ja
Publication of JP2009517406A5 publication Critical patent/JP2009517406A5/ja
Pending legal-status Critical Current

Links

JP2008542538A 2005-11-28 2006-11-28 Il−21受容体アンタゴニスト Pending JP2009517406A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73999505P 2005-11-28 2005-11-28
PCT/US2006/061285 WO2007114861A2 (en) 2005-11-28 2006-11-28 Il-21 receptor antagonists

Publications (2)

Publication Number Publication Date
JP2009517406A JP2009517406A (ja) 2009-04-30
JP2009517406A5 true JP2009517406A5 (cg-RX-API-DMAC7.html) 2011-12-15

Family

ID=38564113

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008542538A Pending JP2009517406A (ja) 2005-11-28 2006-11-28 Il−21受容体アンタゴニスト

Country Status (7)

Country Link
US (3) US7592427B2 (cg-RX-API-DMAC7.html)
EP (1) EP1960433A2 (cg-RX-API-DMAC7.html)
JP (1) JP2009517406A (cg-RX-API-DMAC7.html)
AU (1) AU2006341398B9 (cg-RX-API-DMAC7.html)
CA (1) CA2632218A1 (cg-RX-API-DMAC7.html)
IL (1) IL190686A0 (cg-RX-API-DMAC7.html)
WO (1) WO2007114861A2 (cg-RX-API-DMAC7.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6307024B1 (en) 1999-03-09 2001-10-23 Zymogenetics, Inc. Cytokine zalpha11 Ligand
US20070122413A1 (en) 2005-11-28 2007-05-31 Sivakumar Pallavur V Il-21 antagonists
EP2217268B1 (en) 2007-12-07 2016-05-04 ZymoGenetics, Inc. Anti-human il-21 monoclonal antibodies
US8911722B2 (en) 2009-09-14 2014-12-16 The Regents Of The University Of Colorado, A Body Corporate Modulation of yeast-based immunotherapy products and responses
WO2013096732A2 (en) * 2011-12-23 2013-06-27 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods of treating or preventing viral diseases by blocking interleukin-21
US9823246B2 (en) 2011-12-28 2017-11-21 The Board Of Trustees Of The Leland Stanford Junior University Fluorescence enhancing plasmonic nanoscopic gold films and assays based thereon
DE102014101565A1 (de) * 2013-11-08 2015-05-13 Sartorius Lab Instruments Gmbh & Co. Kg Komparatorwaage mit abnehmbarem Klimamodul
AR099625A1 (es) * 2014-03-21 2016-08-03 Lilly Co Eli Anticuerpos de il-21
AU2015244025B2 (en) 2014-04-08 2019-03-21 Boston Pharmaceuticals Inc. Binding molecules specific for IL-21 and uses thereof
CN107110851B (zh) 2014-11-05 2019-10-22 纳迈达斯生物科技中心 用于增强成像的金属复合物
WO2016140921A1 (en) 2015-03-02 2016-09-09 180 Therapeutics Lp Method of treating a localized fibrotic disorder using an il-33 antagonist
CN118126157A (zh) 2017-08-03 2024-06-04 美国安进公司 白介素-21突变蛋白和治疗方法
MX2020007291A (es) 2018-01-12 2020-09-10 Amgen Inc Anticuerpos anti-pd-1 y metodos de tratamiento.
US12012441B2 (en) 2020-10-26 2024-06-18 Neptune Biosciences Llc Engineered human IL-21 cytokines and methods for using the same
CN114990206B (zh) * 2022-06-02 2023-04-07 中国医学科学院皮肤病医院(中国医学科学院皮肤病研究所) Common γ-chain受体作为药物靶点在制备治疗狼疮性肾炎药物中的应用
WO2024040195A1 (en) 2022-08-17 2024-02-22 Capstan Therapeutics, Inc. Conditioning for in vivo immune cell engineering

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3255699B2 (ja) * 1992-04-23 2002-02-12 味の素株式会社 ヒトIL−2レセプターγ鎖分子
TWI239847B (en) 1997-12-02 2005-09-21 Elan Pharm Inc N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
US6057128A (en) 1998-03-17 2000-05-02 Genetics Institute, Inc. MU-1, member of the cytokine receptor family
US6576744B1 (en) 1998-09-23 2003-06-10 Zymogenetics, Inc. Cytokine receptor zalpha11
US6803451B2 (en) 1998-09-23 2004-10-12 Zymogenetics, Inc. Cytokine receptor zalpha11 polypeptides
ES2279809T3 (es) 2000-04-05 2007-09-01 Zymogenetics, Inc. Receptores de citoquina zalfa11 solubles.
AU2003230834A1 (en) 2002-04-09 2003-10-27 Beth Israel Deaconess Medical Center, Inc. Antagonists of il-21 and modulation of il-21-mediated t cell responses
US20040016010A1 (en) 2002-04-17 2004-01-22 Marion Kasaian IL-21 receptor knockout animal and methods of use thereof
WO2003106497A1 (en) 2002-06-14 2003-12-24 Immunomedics, Inc. Monoclonal antibody pam4 and its use for diagnosis and therapy of pancreatic cancer
MXPA05000655A (es) 2002-07-15 2006-02-22 Harvard College Metodos y composiciones para modular el desarrollo y la funcion de las celulas t helper (th).
MXPA05009556A (es) 2003-03-14 2005-11-16 Wyeth Corp Anticuerpos contra receptor de il-21 humano y sus usos.
RU2005132458A (ru) 2003-03-21 2006-03-20 Уайт (Us) Лечение иммунологических расстройств с использованием агонистов интерлейкина-21/рецептора интерлейкина-21
JP4471721B2 (ja) * 2004-04-20 2010-06-02 独立行政法人産業技術総合研究所 抗インターロイキン21受容体(il−21r)抗体および本抗体を産生するハイブリドーマ
EP1753458A4 (en) 2004-05-19 2009-07-22 Wyeth Corp MODULATION OF IMMUNOGLOBULIN PRODUCTION AND ATOPIC DISORDERS
TWI396686B (zh) * 2004-05-21 2013-05-21 Takeda Pharmaceutical 環狀醯胺衍生物、以及其製品和用法
US20070111941A1 (en) 2004-06-09 2007-05-17 Zymogenetics, Inc. Cytokine receptor zalpha11
MX2007001509A (es) 2004-08-05 2007-03-27 Wyeth Corp Antagonismo de la actividad del receptor de interleuquina 21.
ITRM20040586A1 (it) 2004-11-29 2005-02-28 Giuliani Spa Epitopi antigenici dell'interleuchina-21, anticorpi relativi e loro uso in campo medico.
US20070122413A1 (en) 2005-11-28 2007-05-31 Sivakumar Pallavur V Il-21 antagonists

Similar Documents

Publication Publication Date Title
JP2009517405A5 (cg-RX-API-DMAC7.html)
JP2021532829A5 (cg-RX-API-DMAC7.html)
JP2016520600A (ja) 新規抗体
IL195285A (en) Methods for identifying b cells for expressing antigen-specific antibodies
SG10201803473WA (en) Methods for enhancing immunosuppressive therapy by multiple administration of alpha beta tcr-binding polypeptide
RU2013152816A (ru) АНТИТЕЛО ПРОТИВ ПРОТЕИНТИРОЗИНФОСФАТАЗЫ σ РЕЦЕПТОРНОГО ТИПА ЧЕЛОВЕКА
JP2012526542A5 (cg-RX-API-DMAC7.html)
HK1201279A1 (en) Antibody and methods for selective inhibition of t-cell responses
IL212056A0 (en) Monoclonal antibodies and methods for their use in the detection of cervical disease
RU2010136940A (ru) Антитела против альфа5-бета1 и их применение
RU2016107814A (ru) Новое антитело к tslp-рецептору человека
RU2012127378A (ru) Средства для лечения заболевания
Schardt et al. Discovery and characterization of high-affinity, potent SARS-CoV-2 neutralizing antibodies via single B cell screening
Boshuizen et al. A combination of in vitro techniques for efficient discovery of functional monoclonal antibodies against human CXC chemokine receptor-2 (CXCR2)
US9938343B2 (en) Diagnostic method for determining the presence and amount of human interleukin-3 in a sample using novel IL-3 antibodies
WO2023036127A1 (zh) 一种靶向IL-23p19的抗体或其抗原结合片段及其应用
Tsuboi et al. Generation and functional analysis of monoclonal antibodies against the second extracellular loop of human M3 muscarinic acetylcholine receptor
Lightwood et al. Antibody generation through B cell panning on antigen followed by in situ culture and direct RT-PCR on cells harvested en masse from antigen-positive wells
JP2008503737A5 (cg-RX-API-DMAC7.html)
CN112940125A (zh) 抗vista蛋白的单克隆抗体及其细胞株、制备方法和应用
CN113234159A (zh) 抗lag3蛋白单克隆抗体及其细胞株、制备方法和应用
JP2007534951A5 (cg-RX-API-DMAC7.html)
CN117043187A (zh) GARP/TGFβ1抗体及其应用
JP2017506214A5 (cg-RX-API-DMAC7.html)
CN110272494A (zh) Tim-3抗原、纳米抗体及其筛选和鉴定方法、纳米抗体的应用